Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of R-flurbiprofen Capsules in Healthy Subjects
NCT02206854Phase 1Completed
- Start
- Jun 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tarenflurbil in neuropathic pain. Primary endpoints: Area under the curve at 24 hours, Time to maximum concentration at 24 hours and 2 more. Started Jun 2014; status: completed.
02
Drugs
tarenflurbil
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02206854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206854.